Läkemedel på rekvisition 2024, SLL450, del 2
- Published
- 22 February 2024
- Estimated value
- 60,000,000 kr
- Procedure
- open
- Lots
- 2
- Notice number
- 00110279-2024
- Reference
- 397cfa6d-e465-4ff7-99d2-9bb4e61bd5de
- Official source
- Official source
CPV codes
- 33000000Equipamiento y artículos médicos, farmacéuticos y de higiene personal
Description
Substanser inkluderade i denna upphandling är: aflibercept, aprotinin, asparginas, cyklofosfamid, fluocinolonacetonid, humant normalt immunglobulin för extravaskulärt bruk, idarubicin, klorhexidin, landiolol, pantoprazol, pegaspargas, vasopressin (argipressin), vinflunin. Även adaptrar till nuvarande avtalade produkter önskas.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Accord Healthcare AB | — | — |
| B.Braun Medical AB | — | — |
| Baxter Medical AB | — | — |
| Bayer Aktiebolag | — | — |
| CAMPUS Pharma AB | — | — |
| Jazz Pharmaceuticals Denmark - Svensk filial | — | — |
| Oresund Pharma ApS | — | — |
| Takeda Pharma AB | — | — |
| AOP Orphan Pharmaceuticals GmbH | — | — |
| Horus Pharma Nordic AB | — | — |
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 60,000,000 kr.
- Who is the buyer of this tender?
- The contracting authority is Region Stockholm - Serviceförvaltningen (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.